LeMaitre Vascular

Yahoo Finance • 8 days ago

1 Reason to Avoid LMAT and 1 Stock to Buy Instead

LeMaitre has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 15.5% to $101.53 per share while the index has gained 11.3%. Is now the time to buy LeMaitre, or s... Full story

Yahoo Finance • 12 days ago

3 Healthcare Stocks with Open Questions

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The r... Full story

Yahoo Finance • 23 days ago

LeMaitre to Present at the Bank of America Healthcare Conference

BURLINGTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced today that management will present at the Bank of America Healthcare Conference on Wednesday, May 13, 2026, at 5:15 PM PT. About LeMait... Full story

Yahoo Finance • last month

Lemaitre Vascular (LMAT) is Strengthening Profitability in Vascular Disease Treatment

Conestoga Capital Advisors, an asset management company, released its first-quarter 2026 investor letter. A copy of the letter can be downloaded here. The first quarter of 2026 began with optimism about the domestic economy and attractive... Full story

Yahoo Finance • 2 months ago

Mid-cap healthcare stocks with A grade EPS revisions ahead of earnings

[Heart Health Concept] Eoneren/E+ via Getty Images As Q1 2026 earnings season approaches, the healthcare sector enters reporting season as one of the market's primary laggards, with the Health Care Select Sector SPDR Fund (XLV [https://se... Full story

Yahoo Finance • 2 months ago

Is LeMaitre Vascular, Inc. (LMAT) A Good Stock To Buy Now?

Is LMAT a good stock to buy? We came across a bullish thesis on LeMaitre Vascular, Inc. on FluentInQuality’s Substack. In this article, we will summarize the bulls’ thesis on LMAT. LeMaitre Vascular, Inc.'s share was trading at $110.33 as... Full story

Yahoo Finance • 2 months ago

A LeMaitre Vascular (LMAT) Insider Sold 2,625 Shares for $285K

On March 11, 2026, LeMaitre Vascular(NASDAQ:LMAT) Senior Vice President, Operations, Trent G Kamke, reported the exercise and immediate sale of 2,625 shares of common stock for total proceeds of approximately $285,000, according to this SE... Full story

Yahoo Finance • 2 months ago

Artivion, Intuitive Surgical, GE HealthCare, LeMaitre, and Globus Medical Shares Plummet, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as investors reacted to escalating uncertainty tied to the U.S.-Iran conflict and poli... Full story

Yahoo Finance • 2 months ago

3 Unpopular Stocks We’re Skeptical Of

Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth. Whatever the... Full story

Yahoo Finance • 3 months ago

3 Healthcare Stocks We’re Skeptical Of

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, which has supported the industry’s returns lately - over the past six... Full story

Yahoo Finance • 3 months ago

2 Profitable Stocks with Exciting Potential and 1 We Turn Down

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity". Profits are valuable, b... Full story

Yahoo Finance • 3 months ago

LeMaitre Vascular, Inc. (LMAT): A Bull Case Theory

We came across a bullish thesis on LeMaitre Vascular, Inc. on Compounding Quality’s Substack. In this article, we will summarize the bulls’ thesis on LMAT. LeMaitre Vascular, Inc.'s share was trading at $87.78 as of Feb. LMAT’s trailing an... Full story

Yahoo Finance • 3 months ago

PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx Shares Are Falling, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after a surprisingly hot wholesale inflation report fueled investor concerns about persistent price pressures. The Producer Price Index (PPI), a key measure of inflation at t... Full story

Yahoo Finance • 3 months ago

LeMaitre to Participate at Upcoming Investor Conferences in March

BURLINGTON, Mass., Feb. 27, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in five upcoming investor conferences in March. Leerink Partners Global Healthcare Conferen... Full story

Yahoo Finance • 3 months ago

LeMaitre Vascular Inc. Bottom Line Rises In Q4

(RTTNews) - LeMaitre Vascular Inc. (LMAT) announced a profit for its fourth quarter that Increased, from the same period last year The company's earnings totaled $15.58 million, or $0.68 per share. This compares with $11.18 million, or $... Full story

Yahoo Finance • 6 months ago

Penumbra, Corcept, Elanco, ResMed, and LeMaitre Stocks Trade Up, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a fu... Full story

Yahoo Finance • 7 months ago

LeMaitre to Participate in Upcoming Investor Conferences

BURLINGTON, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in three upcoming investor conferences. Jefferies London Healthcare Conference 2025 Tuesday, No... Full story

Yahoo Finance • 7 months ago

LeMaitre targets 40% Q4 operating income growth and 29% margin as Artegraft expansion accelerates

Earnings Call Insights: LeMaitre Vascular, Inc. (LMAT) Q3 2025 MANAGEMENT VIEW * CEO George LeMaitre highlighted "organic sales growth of 12% and a better-than-expected gross margin" for Q3, noting "several bottom line records, op inco... Full story

Yahoo Finance • 7 months ago

LeMaitre Vascular declares $0.20 dividend

* LeMaitre Vascular (LMAT [https://seekingalpha.com/symbol/LMAT]) declares $0.20/share quarterly dividend [https://seekingalpha.com/pr/20297939-lemaitre-q3-2025-financial-results], in line with previous. * Forward yield [https://seekin... Full story

Yahoo Finance • 8 months ago

LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025

BURLINGTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2025 financial results on Thursday, November 6, 2025, after the market close. The company h... Full story